Contact
searchSearch
HMP Global
Login

Great Debates in Women's Cancers

Great Debates in
Women's Cancers

Kelly McCann, MD, PhD, UCLA
Videos
Sequencing Antibody-Drug Conjugates Among Patients With Breast Cancer
09/18/2025
Kelly McCann, MD, PhD
Kelly McCann, MD, PhD, discusses the sequencing of antibody-drug conjugates for patients with breast cancer.
Kelly McCann, MD, PhD, discusses the sequencing of antibody-drug conjugates for patients with breast cancer.
Kelly McCann, MD, PhD, discusses...
09/18/2025
Oncology
Heather Moore, CPP, PharmD, Duke Cancer Center
Videos
Managing Adverse Events for Patients With Breast Cancer
09/17/2025
Heather Moore, PharmD
Heather Moore, CPP, PharmD, discusses the management of adverse events for patients with breast cancer.
Heather Moore, CPP, PharmD, discusses the management of adverse events for patients with breast cancer.
Heather Moore, CPP, PharmD,...
09/17/2025
Oncology
Shipra Gandhi, MD, Winship Cancer Institute
Videos
An Argument Against Earlier Novel Endocrine Backbones for Breast Cancer
03/27/2025
Shipra Gandhi, MD
Shipra Gandhi, MD, makes the case against moving novel endocrine backbones to earlier lines of therapy in breast cancer.
Shipra Gandhi, MD, makes the case against moving novel endocrine backbones to earlier lines of therapy in breast cancer.
Shipra Gandhi, MD, makes the...
03/27/2025
Oncology
Seth Wander, MD, PhD
Conference Coverage
Earlier Use of Novel Endocrine Backbones for Patients With HR-Positive Breast Cancer
03/26/2025
Seth Wander, MD
Seth Wander, MD, PhD, discusses key considerations for moving novel endocrine backbones into earlier lines of therapy for patients with hormone receptor-positive breast cancer.
Seth Wander, MD, PhD, discusses key considerations for moving novel endocrine backbones into earlier lines of therapy for patients with hormone receptor-positive breast cancer.
Seth Wander, MD, PhD, discusses...
03/26/2025
Oncology
Kelly McCann, Md, PhD, University of California, Los Angeles
Videos
Sequential Use of Antibody-Drug Conjugates for Patients With Breast Cancer
03/25/2025
Kelly McCann, MD, PhD
Kelly McCann, MD, PhD, University of California, Los Angeles, discusses the debate over whether to use antibody-drug conjugates sequentially for patients with breast cancer. Dr McCann discusses the potential for cross-resistance with these...
Kelly McCann, MD, PhD, University of California, Los Angeles, discusses the debate over whether to use antibody-drug conjugates sequentially for patients with breast cancer. Dr McCann discusses the potential for cross-resistance with these...
Kelly McCann, MD, PhD,...
03/25/2025
Oncology
Heather Moore, PharmD, BCOP, CPP, Duke Cancer Center
Videos
Managing Adverse Events in Breast Cancer Treatment
03/25/2025
Heather Moore, PharmD, BCOP, CPP, discusses management of adverse events when treating patients with breast cancer.
Heather Moore, PharmD, BCOP, CPP, discusses management of adverse events when treating patients with breast cancer.
Heather Moore, PharmD, BCOP,...
03/25/2025
Oncology
News
HMP Global’s Great Debates in Solid Tumors events deliver best of three popular oncology conferences
03/19/2025
The best of HMP Global’s three Great Debates programs will be featured in one 2025 series, Great Debates in Solid Tumors, delivering a more comprehensive learning experience for oncology clinicians in the gastrointestinal, women’s and lung...
The best of HMP Global’s three Great Debates programs will be featured in one 2025 series, Great Debates in Solid Tumors, delivering a more comprehensive learning experience for oncology clinicians in the gastrointestinal, women’s and lung...
The best of HMP Global’s three...
03/19/2025
Oncology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use